In endometrial cancer, Takeuchi et al. [60] calculated the combination index (≤1 to define synergistic effects) using the Talalay–Chou method to evaluate the synergistic effect of an ATR inhibitor (VE-8220) combined with CHK1 inhibitor (AZD7762). This evidence concerns the gene ATR and endometrial cancer.